These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 4476721)

  • 1. The effects of hGH treatment on somatomedin levels in the serum (as determined by 35-S uptake into cartilage).
    Schimpff RM; Donnadieu M; Gourmelen M; Girard F
    Horm Metab Res; 1974 Nov; 6(6):494-8. PubMed ID: 4476721
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative determination of somatomedin in human serum ( 35 S uptake by embryonic chick cartilage).
    Schimpff RM
    Biomedicine; 1973 Apr; 19(4):142-7. PubMed ID: 4715574
    [No Abstract]   [Full Text] [Related]  

  • 3. Human somatomedin. Determination, occurrence, biological activity and purification.
    Hall K
    Acta Endocrinol Suppl (Copenh); 1972; 163():1052. PubMed ID: 4538721
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative determination of somatomedin in human serum (35S uptake by embryonic chick cartilage).
    Schimpff RM; Donnadieu M
    Biomedicine; 1973 Apr; 19(4):142-7. PubMed ID: 4731987
    [No Abstract]   [Full Text] [Related]  

  • 5. [Response to treatment with HGH (human growth hormone) in 33 patients with idiopathic hypopituitarism].
    Cacciari E; Cicognani A; Pirazzoli P; Salardi S; Tassoni P; Bernardi F; Zappulla F; Mazzanti L
    Minerva Pediatr; 1975 Nov; 27(36):1991-8. PubMed ID: 1186647
    [No Abstract]   [Full Text] [Related]  

  • 6. The Snell-dwarfmouse. II. Sulphate and thymidine incorporation in costal cartilage and somatomedin levels before and during growth hormone and thyroxine therapy.
    van Buul S; Van den Brande JL
    Acta Endocrinol (Copenh); 1978 Dec; 89(4):646-58. PubMed ID: 716773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatomedin, transferrin and amino-acids in serum following injection of human growth hormone in children with growth disease.
    Repellin AM; Schimpff RM; Georges P; Job JC
    Horm Metab Res; 1984 Oct; 16(10):539-43. PubMed ID: 6500489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of blood somatomedin during childhood in normal subjects and in delayed growth].
    Pierson M; Grignon G; Malaprade D; Hartemann P
    Ann Biol Clin (Paris); 1976; 34(1):11-8. PubMed ID: 970694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum somatomedin activity assayed by the enhancement of proteoglycan sulphation using chick embryo chondrocytes in normal children at various ages and children of short stature.
    Maesaka H; Yokoya S; Tachibana K; Suwa S; Yamagata T
    Acta Endocrinol (Copenh); 1982 Nov; 101(3):325-32. PubMed ID: 7148331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.
    van Buul-Offers S; Van den Brande JL
    Horm Metab Res; 1985 Jan; 17(1):20-4. PubMed ID: 3967843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatomedin and the regulation of skeletal growth.
    Elders MJ; Wingfield BS; McNatt ML; Lee JA; Hughes ER
    Ann Clin Lab Sci; 1975; 5(6):440-51. PubMed ID: 1200618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum inorganic sulfate and apparent somatomedin activity in an assay using chick embryo cartilage.
    Audhya TK; Gibson KD
    Endocrinology; 1974 Dec; 95(6):1614-20. PubMed ID: 4279815
    [No Abstract]   [Full Text] [Related]  

  • 16. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 17. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of skeletal growth by sulfation factor.
    Daughaday WH
    Adv Intern Med; 1971; 17():237-63. PubMed ID: 4949905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of somatomedin activity in blood using a biological method].
    Schüllerová M; Schreiberová O; Marek J
    Cesk Fysiol; 1981; 30(6):537-44. PubMed ID: 7317961
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of growth hormone, prolactin and thyroxine on body wegith, somatomedin-like activity and in-vivo sulphation of cartilage in hypopituitary dwarf mice.
    Holder AT; Wallis M; Biggs P; Preece MA
    J Endocrinol; 1980 Apr; 85(1):35-41. PubMed ID: 7391723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.